Bioscience

AlloSource helps NASA in antimicrobial study on International Space Station

AlloSource helps NASA in antimicrobial study on International Space Station

CENTENNIAL -- AlloSource , dedicated to advancing the science and use of transplantable allogeneic cells and tissue, announced it served on a contributing science team to NASA's Jet Propulsion... Read More

Tuesday December 11, 2018 0 comments Tags: Centennial, AlloSource, NASA, ISS, Peter Stevens, NASA JPL

Clovis Oncology announces positive hearing for Rubraca in Europe

Clovis Oncology announces positive hearing for Rubraca in Europe

BOULDER -- Clovis Oncology, Inc. (NASDAQ:CLVS) today announced after opposition proceedings at The Hague, Netherlands, that the European Patent Office upheld claims of European Patent 2534153... Read More

Wednesday December 5, 2018 0 comments Tags: Boulder, Clovis Oncology, Rubraca, Patrick J. Mahaffy, Rucaparib

Parkinson's Foundation to host first-ever medical marijuana and Parkinson's Disease conference in Denver in March 2019

Parkinson's Foundation to host first-ever medical marijuana and Parkinson's Disease conference in Denver in March 2019

DENVER -- The Parkinson's Foundation will host its first-ever conference focused on medical marijuana and Parkinson's disease (PD) inDenver March 6-7, 2019. "The Parkinson's Foundation is... Read More

Wednesday December 5, 2018 0 comments Tags: Denver, Parkinson's Foundation, Benzi Kluger

Ampio provides update on Ampion regulatory review

Ampio provides update on Ampion regulatory review

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) reports favorable regulatory and peer-review on the status of Ampion, the companys drug for osteoarthritis of the knee. ... Read More

Tuesday November 27, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion

Machavert Pharmaceuticals reports progress in MP1000 cancer drug development

Machavert Pharmaceuticals reports progress in MP1000 cancer drug development

AURORA -- Machavert Pharmaceuticals , a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer, recently announced the progress of its MP1000... Read More

Monday November 26, 2018 0 comments Tags: Aurora, Machavert, Neal Goodwin, MP 1000

Avista Pharma Solutions to be acquired by Cambrex

Avista Pharma Solutions to be acquired by Cambrex

DENVER -- New Jersey-based Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs) and finished dosage forms,... Read More

Wednesday November 21, 2018 0 comments Tags: Denver, Avista Pharma Solutions, Cambrex, Pat Walsh, Steve Klosk

CSU chemists arm drug hunters with latest tool for new drug discovery

CSU chemists arm drug hunters with latest tool for new drug discovery

FORT COLLINS -- If pharmaceutical chemists are the drug hunters who discover new medicines, scientists like Andrew McNally and Robert Paton are the armorers -- deft creators who arm drug... Read More

Tuesday November 20, 2018 0 comments Tags: Fort Collins, CSU, Andrew McNally, Robert Paton

Clovis Oncology announces second patent for Rucaparib high dose

Clovis Oncology announces second patent for Rucaparib high dose

BOULDER -- Clovis Oncology , Inc. (NASDAQ:CLVS) today announced the United States Patent and Trademark Office issued United States Patent 10,130,636 with claims directed to methods of treating... Read More

Tuesday November 20, 2018 0 comments Tags: Boulder, Clovis Oncology, Rucaparib, Patrick J. Mahaffy